Structural variations of transketolases over the evolution from bacteria to higher eukaryotes: In silico/in vitro study
Methods in Enzymology · 2025
DOI: 10.1016/bs.mie.2025.07.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods in Enzymology, 2025. Verfasst von Rainier-Numa Georges und 3 weiteren Autor:innen. Beteiligte Einrichtung: ICBMS UMR 5246, CNRS, Universite Claude Bernard Lyon 1, Villeurbanne, France. Electronic address: rainier-numa.georges@univ-lyon1.fr. Hauptthemen laut MEDLINE: Transketolase, Bacteria, Evolution, Molecular. Die Arbeit nennt 47 Literaturangaben.
Abstract (Originalsprache)
Transketolases are ubiquitous enzymes that predominantly control the pentose phosphate pathway and are involved in the synthesis of aromatic amino acids, nucleotides and the regulation of oxidative stress. The development of specific inhibitors of human pathogen transketolases could provide a new class of antibiotics. To answer this question, it is necessary to compare human transketolase with those of pathogenic organisms to ensure they are sufficiently different. This chapter presents two protocols for the expression of human and of thirteen transketolases from priority pathogenic organisms, in order to obtain six new experimental structures by X-ray diffraction. Resolution of the electron density maps was performed using in silico models, using detailed protocol for their generation and validation. The experimental structures and models made possible to map and compare for the first time active sites and monomer-monomer interfaces of transketolases. Being at least 50 residues shorter, animal transketolases have evolved differently from those of bacteria, fungi and parasites. The comparison of the monomer-monomer interface also demonstrates that this zone is highly specific to each transketolase, in contrast to their conserved active site. However, in both areas, human transketolase has a significantly higher number of non-covalent bonds than pathogen transketolases, probably to maintain its shorter structure. These observations suggest that pathogen transketolases can be specifically inhibited, particularly targeting the monomer-monomer interface, without affecting human transketolase activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ICBMS UMR 5246, CNRS, Universite Claude Bernard Lyon 1, Villeurbanne, France. Electronic address: rainier-numa.georges@univ-lyon1.fr.
- Molecular Microbiology and Structural Biochemistry, UMR 5086, CNRS-Université de Lyon, Lyon, France.
- Institut de Chimie de Clermont-Ferrand (ICCF), Université Clermont Auvergne, CNRS, SIGMA Clermont, Clermont-Ferrand, France.
- ICBMS UMR 5246, CNRS, Universite Claude Bernard Lyon 1, Villeurbanne, France.
Zitieren
APA
Georges, R. N., Ballut, L., Charmantray, F., & Doumèche, B. (2025). Structural variations of transketolases over the evolution from bacteria to higher eukaryotes: In silico/in vitro study. Methods in Enzymology. https://doi.org/10.1016/bs.mie.2025.07.001
Vancouver
Georges RN, Ballut L, Charmantray F, Doumèche B. Structural variations of transketolases over the evolution from bacteria to higher eukaryotes: In silico/in vitro study. Methods in Enzymology. 2025. doi:10.1016/bs.mie.2025.07.001
BibTeX
@article{Georges2025,
author = {Georges, Rainier-Numa and Ballut, Lionel and Charmantray, Franck and Doumèche, Bastien},
title = {Structural variations of transketolases over the evolution from bacteria to higher eukaryotes: In silico/in vitro study},
journal = {Methods in Enzymology},
year = {2025},
doi = {10.1016/bs.mie.2025.07.001}
}
EUVIMED